3 of the Best Stock Buys in Telemedicine Sector
Telemedicine stocks had a roller coaster ride for most of 2020. What’s there for the investors in the future? Let’s see! The health sector has benefited the most from the global pandemic, increasing the significance of the healthcare stocks. In that premise, the telehealth sector has also become a success story and has a prosperous […]
Let’s take a glance at why Exela Technologies, Inc. (XELA) broke barriers in the AH session
Exela Technologies, Inc. (NASDAQ: XELA) shares booms in the post-market session as it rose 12.46% to $0.401 after a leading global business process automation company XELA, announced that it has entered into a 5-year, $145 million term loan facility with Angelo. Gordon, a global alternative investment firm. There is an initial funding provision of approximately […]
An Eye-Opener for investors: VistaGen Therapeutics, Inc. (VTGN) roared in the late trading
VistaGen Therapeutics, Inc. (VTGN) surged as high as 24.73% to $1.16 in the after-market as a biopharmaceutical company dedicated to developing new medicines for anxiety, depression, and other disorders of the central nervous system, announced it had commenced an underwritten public offering of its common stock, equal to $0.001 per share, and its Series D […]
3 Best Streaming Stocks for Long-term Investment
The streaming industry has been on a boom since the pandemic. The lockdown restrictions have driven more audience towards streaming platforms. Streaming stocks have been a trending sector in the stock market this year. There are few notable stocks in the streaming industry that have an upbeat long-term prospect. The streaming market has some strong […]
This hot update rushed CTD Holdings Inc. (CYTH) in the Pre-market session
CTD Holdings Inc. (NASDAQ: CYTH) a biotechnology company that develops cyclodextrin-based products for the treatment of diseases rushed in the pre-market session more than 70% to $8.15 after the Analysts from the Maxim Group upgraded the stock to BUY with the price of $12.00. CTD Holdings Inc. (NASDAQ: CYTH) stock has a Market Cap of […]
Key update bolstered Sonoma Pharmaceuticals (SNOA) stock price in the After hours
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) surged 25.82% to $9.6 in the after-hours session following the reports that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn Technology products into the dental market and it has already taken its first order. Sonoma manufactures Endocyn, a Microcyn Technology product, […]
Top Makeup Stocks to Watch For in 2021
With the vaccine news and things coming to normal, makeup stocks can boom in the next year. As we head into 2021, spaces will open for each industry to see growth in their respective business segments. Also, with vaccine deployment expected in late December and early January, things are likely to get better. However, there […]
Sensational news heaved Surface Oncology (SURF) shares higher in the Postmarket hours
Today, Surface Oncology (Nasdaq: SURF) surged 10.46% to 9.4 in the after-hours as it officially announced an agreement with GSK to develop and commercialize Surface Oncology’sOncology’s preclinical program, SRF813, an antibody that aims to inhibit PVRIG, an inhibitory protein expressed on natural killer cells (NK cells) and T cells. As part of the agreement, GSK […]
Is that why Mesoblast Limited (MESO) dipped in the early morning trading?
Mesoblast Limited (Nasdaq:MESO) shares were plunging -30.07 to $9.45 in the premarket session recently released an update on the clinical trial of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory distress syndrome (ARDS) caused by infection with COVID-19 following a third interim analysis of the first 180 patients in the trial by the […]
Hot news making Mereo BioPharma Group plc (MREO) trend so fast in the late hours
Mereo BioPharma Group plc (Nasdaq: MREO) shares jumped 38.46% to $3.06 in the After-market hours after the joint statement by Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE), and Mereo BioPharma (Nasdaq: MREO) that both companies have signed a patent and partnership arrangement for setrusumab, a monoclonal antibiotic medicinal medicine, Setrusumab is a fully human monoclonal antibody investigational […]
